Related Experiment Videos

Expression of NPAT, a novel substrate of cyclin E-CDK2, promotes S-phase entry

J Zhao1, B Dynlacht, T Imai

  • 1Laboratory of Molecular Oncology, Massachusetts General Hospital (MGH) Cancer Center, Charlestown, Massachusetts 02129, USA. zhao@helix.mgh.harvard.edu

Genes & Development
|March 21, 1998
PubMed

Insights

Researchers identified NPAT as a novel substrate for cyclin E-CDK2, a key regulator of cell cycle progression. NPAT protein levels peak at the G1/S boundary, and its overexpression accelerates S-phase entry, suggesting its role in cell cycle regulation.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Cyclin-dependent kinases (CDKs) are crucial regulators of the cell cycle.
  • Identifying CDK substrates is essential for understanding cell cycle control mechanisms.

Purpose of the Study:

  • To identify novel physiological substrates of CDKs.
  • To investigate the role of the NPAT gene in cell cycle regulation.

Main Methods:

  • Developed a screening method to identify novel CDK substrates.
  • Utilized in vivo association assays to study NPAT and cyclin E-CDK2 interaction.
  • Analyzed NPAT protein levels during the cell cycle.
  • Investigated the effect of NPAT overexpression on S-phase entry.

Main Results:

  • Identified NPAT as a novel CDK substrate.
  • Demonstrated that NPAT associates with and is phosphorylated by cyclin E-CDK2 in vivo.
  • Observed that NPAT protein levels peak at the G1/S boundary.
  • Found that NPAT overexpression accelerates S-phase entry, an effect enhanced by cyclin E-CDK2 coexpression.

Conclusions:

  • NPAT is a physiological substrate of cyclin E-CDK2.
  • NPAT plays a significant role in regulating the G1/S transition and promoting S-phase entry.

Related Concept Videos